Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Home health occupational therapy should be included before chemotherapy to improve patient care.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Fad diets and supplements from social media can cause skin and hair problems.

Host cells are crucial for the maturation of reconstructed hair follicles.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

COVID-19 infection is linked to temporary hair loss in Egyptian women.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Balancing testosterone may reduce COVID-19 severity.

Children may have lingering respiratory issues after recovering from COVID-19.

HPV type 56 can hide in hair follicles even without visible warts.